ARC Dialysis

What ARC Dialysis does

ARC Dialysis is a private, for-profit clinical services provider founded in 2018 and headquartered in Miami, United States. The company delivers chronic kidney failure and end-stage renal disease (ESRD) dialysis services, operating in a regulated healthcare segment where continuity of care and clinical licensure are foundational to operations. ARC maintains a small workforce of 11-50 employees and is led by Chief Executive Officer Fred Dumenigo. Geographic footprint evidence suggests operations extending to Texas in addition to the Miami headquarters, indicating multi-state service delivery.

The company's core offering is hemodialysis treatment for patients with chronic and end-stage renal disease — a recurring, clinically necessary service rather than a transactional product. No proprietary technology platform, software stack, or AI-enabled clinical tooling is disclosed in available sources, and the company's website content was not retrievable for technical detail. The business model is consistent with standard US dialysis clinic economics: recurring per-treatment reimbursement, predominantly from Medicare/Medicaid and commercial payers, though no ARC-specific payer mix or pricing detail is publicly disclosed.

ARC's most material documented strategic action is the renewed and extended product purchase agreement with Rockwell Medical, a supplier of dialysis-related products. The two-year renewal (with options for further renewal periods) provides supply continuity for dialyzers and related consumables and signals a stable supplier relationship. Beyond this, there is no publicly disclosed funding history, M&A activity, leadership turnover, or product launches in the input data, leaving most growth and competitive positioning questions unanswerable from available evidence.

Name

ARC Dialysis

Website

https://arcdialysis.com

Company type

Private

Founded year

2018

Headcount range

11–50 employees

Short description

ARC Dialysis is a private Miami-based clinical operator founded in 2018 that provides chronic kidney failure and end-stage renal disease hemodialysis services, operating across multiple US states with a renewed multi-year supply partnership with Rockwell Medical.

Ownership category

akta.pro rank

Product category

Dialysis Services

NAICS

Kidney Dialysis Centers (621492)

akta.pro primary industry

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)

akta.pro secondary industry

Outpatient Dialysis & Kidney Care Centers (HLAFABAE)

Keywords

• Hemodialysis services
• End-stage renal disease
• Chronic kidney failure
• Outpatient dialysis care
• Renal disease treatment

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure

Core offering

ARC Dialysis provides chronic kidney failure and end-stage renal disease dialysis services. The company delivers hemodialysis care to patients with kidney disease and maintains a long-term product supply relationship with Rockwell Medical for dialysis-related consumables.

Differentiator

Problem solved

Functional benefit

Products and services

• Hemodialysis services for chronic kidney failure and ESRD

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Rockwell MedicalcoreStrategic or Co-development PartnerRockwell Medical has renewed and extended its product purchase agreement with ARC Dialysis (referred to as aQua Dialysis in the source) for two years with options for additional renewal periods. The deal includes supply commitments of dialysis-related products, reflecting a long-standing relationship and confidence in product quality and service.
• Rockwell MedicalcoreStrategic or Co-development PartnerRockwell Medical renewed and extended its product purchase agreement with ARC Dialysis (referred to as aQua Dialysis in the source), a provider of hemodialysis services in Texas, for two years with options for renewal. The agreement ensures that Rockwell will supply dialyze-related products, reinforcing their ongoing partnership.

Expansion highlights2 records

Direct peers

• DaVita: Largest U.S. outpatient dialysis services operator with ~3,000 clinics; the dominant direct competitor to any independent dialysis provider, including ARC Dialysis, since both deliver in-center hemodialysis to ESRD patients under the same reimbursement regime.
• Satellite Healthcare: Non-profit dialysis provider operating a network of outpatient kidney care centers primarily in California; a direct peer in operating-model terms (chronic, recurring ESRD care) and a potential strategic comparator for ARC's patient-quality and outcomes narrative.
• U.S. Renal Care: Mid-sized U.S. dialysis services platform with several hundred clinics across multiple states; a closer-size direct peer to ARC than DaVita/Fresenius, competing in many of the same secondary and tertiary markets and against the same value-based contracting opportunities.
• Fresenius Medical Care: Global #1 dialysis services and products company, operating thousands of U.S. dialysis clinics through Fresenius Kidney Care; the second dominant direct competitor with which ARC competes for patients, nephrologist referrals, and commercial-payer contracts.
• Innovative Renal Care: U.S. mid-market dialysis services operator (successor to American Renal Associates) running hundreds of clinics; comparable to ARC in focusing on chronic kidney failure and ESRD outpatient dialysis and competing for the same set of regional payers and nephrology group relationships.

Emerging players

• Dialyze Direct: Specialty dialysis provider focused on in-facility (SNF) and home hemodialysis for elderly and nursing-home patients; a direct overlap on the ESRD population ARC serves, with a different care-setting angle that makes it a relevant emerging player to benchmark strategies against.
• Strive Health: Value-based kidney care company partnering with nephrologists and dialysis operators under ESRD risk arrangements; an emerging peer rather than a direct clinic competitor, but one whose contracting model increasingly defines the demand environment for independent dialysis clinics such as ARC Dialysis.
• Cricket Health: Tech-enabled kidney care company delivering CKD/ESRD care (formerly also operating clinics via InterWell) with a heavy focus on home dialysis and value-based care contracts; overlaps with ARC on the patient population but competes via a virtual-first, home-modality model.
• Concerto Renal Services: Specialty dialysis provider operating dialysis centers inside skilled nursing facilities and acute-care hospitals; comparable to ARC on the ESRD population and on the small/mid-sized specialty operator profile, with a different distribution channel.

Others

• Outset Medical: Manufacturer of the Tablo in-center and home hemodialysis system; not a direct services competitor, but an adjacent / enabling peer whose technology roadmap (compact, easy-to-use home dialysis consoles) directly affects the operational economics of clinics like ARC and shapes modality-mix decisions.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/KidneyCareARC
• LinkedInlinkedin.com/company/arc-dialysis-perrine-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARC Dialysis